Logo main
  • 企業・知財を促進
    • スタートアップ企業一覧
    • IP&技術一覧
  • ヘルプを取得
    • 質問を検索
    • プロジェクトを投稿
    • 専門家Directoryを検索
  • リソース
    • ドキュメントセンター
    • 特許を検索
    • 専門家の記事・ブログ
  • ニュース
    • Tech&IPニュース
  • マイアカウント
  • ログイン
  • 専門家向け
  • Icon us

特許

68,020 件
全IP種別
PATENTFIELDで検索
IPを掲載
権利維持

SH3 binding peptides

The classical SH3 domain is usually found in proteins that interact with other proteins and mediate assembly of specific protein complexes, typically via binding to proline-rich peptides in their r...

権利維持

Viral infection treatment

A viral disease (or viral infection) occurs when an organism's body is invaded by pathogenic viruses, and infectious virus particles (virions) attach to and enter susceptible cells.

権利維持

Ragweed allergy

Ragweed pollen is a common allergen. A single plant may produce about a billion grains of pollen per season,[9][10] and the pollen is transported on the wind. It causes about half of all cases of p...

係属中

Cross-linking proteinaceous...

Cross-linking proteinaceous material

権利維持

Ciliary dyskinesia

Primary ciliary dyskinesia (PCD), also known as immotile ciliary syndrome, is a rare, ciliopathic, autosomal recessive genetic disorder that causes a defect in the action of the cilia lining the re...

権利維持

Hologram

Holography is the science and practice of making holograms. Normally, a hologram is a photographic recording of a light field, rather than of an image formed by a lens, and it is used to display a ...

権利維持

Inhibition of retroviral in...

Integrase inhibitors, also known as integrase strand transfer inhibitors (INSTIs), are a class of antiretroviral drug designed to block the action of integrase, a viral enzyme that inserts the vira...

権利維持

Delignification of chemical...

Chemical pulps, such as those from the kraft process or sulfite pulping, contain much less lignin than mechanical pulps, (<5% compared to approximately 40%). The goal in bleaching chemical pulps is...

権利維持

Mycoplasma genitalium

Mycoplasma genitalium is a small pathogenic bacterium that lives on the ciliated epithelial cells of the urinary and genital tracts in humans. Its existence was first reported in 1981,[2] and was e...

権利維持

Human respiratory syncytial...

Human respiratory syncytial virus (RSV) is a virus that causes respiratory tract infections. It is a major cause of lower respiratory tract infections and hospital visits during infancy and childho...

権利維持

Giardiasis

Giardiasis (popularly known as beaver fever)[1] is a zoonotic parasitic disease caused by the flagellate protozoan Giardia lamblia (also sometimes called Giardia intestinalis and Giardia duodenalis...

権利維持

Etoposide analogs

Etoposide, etoposide phosphate or VP-16 (current brand name: Etopophos, according to FDA Orange Book) is a cytotoxic anticancer drug which belongs to the topoisomerase inhibitor drug class.

係属中

Fluorescent detection of nu...

Fluorescent detection of nucleic acids

係属中

Cationic polymerization in CO2

Cationic polymerization in CO2

係属中

Peptide libraries

A peptide library is a tool for protein related study. A peptide library contains a great number of peptides that have a systematic combination of amino acids. Usually, peptide library is synthesiz...

係属中

Totally synthetic affinity ...

Totally synthetic affinity reagents

権利維持

Retained pulmonary secretio...

Retained pulmonary secretion treatment

係属中

Delta hepatitis virus

Hepatitis D, also referred to as hepatitis D virus (HDV) and classified as Hepatitis delta virus, is a disease caused by a small circular enveloped RNA virus. It is one of five known hepatitis viru...

係属中

Enzymes for cleaving/ligat...

Enzymes for cleaving/ligating DNA

係属中

PYY antagonists

Peptide YY (PYY) also known as peptide tyrosine tyrosine or pancreatic peptide YY3-36 is a peptide that in humans is encoded by the PPY gene.[1] Peptide YY is a short (36-amino acid) peptide releas...

  • 最初
  • 前
  • …
  • 321
  • 322
  • 323
  • 324
  • 325
  • 326
  • 327
  • 328
  • 329
  • …
  • 次
  • 最後
イノベーションと知的財産権のためのone-stop shop 今すぐ参加

IP Nexusについて

IP Nexusは、大学・研究機関と連携して新規技術の潜在的なビジネス価値を解明し、技術シーズ・スタートアップ企業を成功へと導かせ、投資家やその他のステークホルダーに貴重なリターンを生み出す知的財産(IP)の商業化企業です。テクノロジーとライフサイエンスにフォーカスしたハイポテンシャルな発明を早期に特定してコマーシャルディレクション、資金調達の専門知識およびマネジメント能力を提供します。アジア地域に特化した専門知識によりアジア地域にフォーカスしています。

免責事項

IP Nexusは、Ask an ExpertとService Marketplaceを提供しています。Ask an ExpertとService Marketplaceは、インタラクティブなオンラインサービスであり、迅速かつ容易にビジネスのための法的相談や法的サービスを見つけることができます。IP Nexusは、法律事務所ではなく、法的助言、法律家の斡旋などの法的サービスを提供することはなく、自ら法的代理を行うことはありません。

コンテンツ

  • 価格
  • よくある質問
  • 知的財産権(IP)の保護
  • 知的財産権(IP)の種類
  • 知的財産権(IP)に関する申し立て
  • 我々のチームについて
  • スタートアップ
  • お問い合せ
  • ブランド資産
  • 利用規約
  • プライバシーポリシー
  • PATENTFIELDで特許を検索

ニュースレター

購読

言語設定

Icon us

Logo gray © 2025 IP Nexus. All Rights Reserved.

レポート内容

      問い合わせフォーム